Aurobindo Pharma Ltd. — filings
Every filing on record for this company. Each row opens the document it names.
| Filing | Period | Scope / kind | Filed | Document |
|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_36105_12662_29052018055408_WEB.xml |
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_36123_12697_29052018063057_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_40617_58875_13112018123658_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_40617_58875_13112018123658_WEB_2.x |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_42485_80512_08022019122455_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_42485_80512_08022019122455_WEB_2.x |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_50218_166178_13112019042933_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_50270_166486_13112019054242_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_52712_216024_07022020113354_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_52713_216028_07022020113635_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55596_263405_04062020010438_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55597_263408_04062020010720_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_60029_306050_13082020105230_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_60030_306054_13082020105707_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_64595_360040_12112020023217_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_64597_360048_12112020023653_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67874_405707_11022021124423_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67879_405722_11022021124944_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_70771_453830_31052021055540_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_70772_453845_31052021061054_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_75233_504977_12082021085820_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_75234_504984_12082021090233_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_77994_552742_09112021032759_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_77997_552748_09112021033154_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_81847_605994_10022022010821_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_81850_606004_10022022011550_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_86999_670532_31052022053520_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_87002_670551_31052022053711_WEB.xm |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_654877_2540_12082022115308_WEB.xml |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_654890_2540_12082022115308_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_866624_4881_12112022203610_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_866751_4881_12112022203639_WEB.xml |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89309_790438_10022023120852.xml |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89310_790441_10022023121149.xml |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_93207_855628_27052023100858.xml |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_93209_855635_27052023101002.xml |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_97024_917549_12082023075206.xml |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_97029_917568_12082023075753.xml |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100244_984813_10112023020858.xml |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100248_984831_10112023021212.xml |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_103388_1051463_10022024074143.xml |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_103389_1051468_10022024074438.xml |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_107278_1139436_25052024093038.xml |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_107279_1139442_25052024093242.xml |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_111334_1220634_10082024080451.xml |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_111335_1220639_10082024080709.xml |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_114798_1303289_09112024085916.xml |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_114799_1303292_09112024090136.xml |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_118971_1373813_06022025100416.xml |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_118972_1373816_06022025100611.xml |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1452169_27052025 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1452173_27052025 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1502262_04082025 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1502271_04082025 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1566248_05112025 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1566250_05112025 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1622073_09022026 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1622074_09022026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1671038_21052026 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1671039_21052026 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1708705_05082026 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1708706_05082026 |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-08-10T12:03:58 | Main_Ind_As_524804_108201812347.xml |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-08-10T12:03:58 | Main_Ind_As_524804_108201812546.xml |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-13T13:06:31 | Main_Ind_As_524804_13112018114045.xml |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-13T13:06:31 | Main_Ind_As_524804_13112018114228.xml |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-02-08T11:36:13 | Main_Ind_As_524804_822019113555.xml |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-02-08T11:36:13 | Main_Ind_As_524804_822019113738.xml |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-29T13:06:34 | Main_Ind_As_524804_29520191231.xml |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-29T13:06:34 | Main_Ind_As_524804_295201912514.xml |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-08-08T11:28:47 | Main_Ind_As_524804_882019112835.xml |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-08-08T11:28:47 | Main_Ind_As_524804_882019113026.xml |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-11-13T17:43:25 | Main_Ind_As_524804_13112019171226.xml |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-11-13T17:43:25 | Main_Ind_As_524804_1311201917728.xml |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-07T12:13:10 | Main_Ind_As_524804_722020112034.xml |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-07T12:13:10 | Main_Ind_As_524804_72202011225.xml |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-06-04T12:59:55 | Main_Ind_As_524804_462020125929.xml |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-06-04T12:59:55 | Main_Ind_As_524804_46202013038.xml |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-08-13T10:45:31 | Main_Ind_As_524804_1382020104518.xml |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-08-13T10:45:31 | Main_Ind_As_524804_1382020104711.xml |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-12T15:20:31 | Main_Ind_As_524804_12112020141439.xml |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-12T15:20:31 | Main_Ind_As_524804_12112020141639.xml |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-11T13:04:32 | Main_Ind_As_524804_1122021122316.xml |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-11T13:04:32 | Main_Ind_As_524804_112202112252.xml |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-31T18:43:28 | Main_Ind_As_524804_3152021174552.xml |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-31T18:43:28 | Main_Ind_As_524804_3152021174718.xml |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-08-13T08:49:59 | Main_Ind_As_524804_1282021205237.xml |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-08-13T08:49:59 | Main_Ind_As_524804_128202120558.xml |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-09T15:54:46 | Main_Ind_As_524804_911202115148.xml |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-09T15:54:46 | Main_Ind_As_524804_9112021151543.xml |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-10T13:33:44 | Main_Ind_As_524804_1022022125257.xml |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-10T13:33:44 | Main_Ind_As_524804_1022022125433.xml |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-31T17:27:12 | Main_Ind_As_524804_315202216345.xml |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-31T17:27:12 | Main_Ind_As_524804_315202216613.xml |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-08-13T11:34:34 | Main_Ind_As_524804_1282022114255.xml |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-08-13T11:34:34 | Main_Ind_As_524804_128202211454.xml |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-13T13:36:30 | Main_Ind_As_524804_12112022202848.xml |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-13T13:36:30 | Main_Ind_As_524804_12112022203054.xml |
| Annual report | 1997-03-31 | grade B | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-1997.PDF |
| Annual report | 1998-03-31 | grade B | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-1998.PDF |
| Annual report | 1999-03-31 | grade B | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-1999.PDF |
| Annual report | 1999-03-31 | grade A | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2000.PDF |
| Annual report | 2001-03-31 | grade A | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2001.PDF |
| Annual report | 2002-03-31 | grade A | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2002.PDF |
| Annual report | 2003-03-31 | grade B | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2003.PDF |
| Annual report | 2004-03-31 | grade B | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2004.PDF |
| Annual report | 2005-03-31 | grade B | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2005.PDF |
| Annual report | 2007-03-31 | grade A | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2007.PDF |
| Annual report | 2008-03-31 | grade A | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2008.PDF |
| Annual report | 2009-03-31 | grade A | nan | AUROBINDO_PHARMA_LTD-524804-MARCH-2009.PDF |
| Annual report | 2010-03-31 | grade A | nan | 5248040310.pdf |
| Annual report | 2011-03-31 | grade A | 2011-10-04T00:00:00 | 5248040311.pdf |
| Annual report | 2012-03-31 | grade A | 2012-07-17T00:00:00 | 5248040312.pdf |
| Annual report | 2014-03-31 | grade A | 2014-08-02T00:00:00 | 5248040314.pdf |
| Annual report | 2015-03-31 | grade A | 2015-08-03T00:00:00 | 5248040315.pdf |
| Annual report | 2016-03-31 | grade A | 2016-08-29T00:00:00 | 5248040316.pdf |
| Annual report | 2017-03-31 | grade A | 2017-09-04T00:00:00 | 5248040317.pdf |
| Annual report | 2018-03-31 | grade A | 2018-09-04T00:00:00 | 5248040318.pdf |
| Annual report | 2019-03-31 | grade B | 2019-08-05T00:00:00 | 5248040319.pdf |
| Annual report | 2020-03-31 | grade A | 2020-08-04T00:00:00 | 5248040320.pdf |
| Annual report | 2021-03-31 | grade A | 2021-08-04T00:00:00 | 69269524804_25_08_21.pdf |
| Annual report | 2022-03-31 | grade A | 2022-07-09T00:00:00 | 73589524804.pdf |
| Annual report | 2023-03-31 | grade A | 2023-08-01T19:17:40.34 | 0aa8e6e6-da93-48a3-a74d-9d50683dc2a7.pdf |
| Annual report | 2024-03-31 | grade A | 2024-08-05T17:40:31.51 | c2f11ada-795d-4215-acbf-3df412cdc882.pdf |
| Annual report | 2025-03-31 | grade A | 2025-08-14T15:22:52.49 | 0e3a5b88-6f3b-4a5d-8d07-7186fd4b1f25.pdf |
| Annual report | 2026-03-31 | grade A | 2026-08-03T18:32:54.987 | ec25ad91-8862-484e-b848-03b3d5e520c9.pdf |
| Concall | 2018-12-31 | TRANSCRIPT | — | Date_20190222_Aurobindo Pharma Ltd._Concal_Q3FY19.pdf |
| Concall | 2019-03-31 | TRANSCRIPT | — | Date_20190614_Aurobindo Pharma Ltd._Concal_Q4FY19.pdf |
| Concall | 2019-06-30 | TRANSCRIPT | — | Date_20190819_Aurobindo Pharma Ltd._Concal_Q1FY20.pdf |
| Concall | 2019-09-30 | TRANSCRIPT | — | Date_20191128_Aurobindo Pharma Ltd._Concal_Q2FY20.pdf |
| Concall | 2019-12-31 | TRANSCRIPT | — | Date_20200224_Aurobindo Pharma Ltd._Concal_Q3FY20.pdf |
| Concall | 2020-03-31 | TRANSCRIPT | — | Date_20200618_Aurobindo Pharma Ltd._Concal_Q4FY20.pdf |
| Concall | 2020-06-30 | TRANSCRIPT | — | Date_20200825_Aurobindo Pharma Ltd._Concal_Q1FY21.pdf |
| Concall | 2020-09-30 | TRANSCRIPT | — | Date_20201127_Aurobindo Pharma Ltd._Concal_Q2FY21.pdf |
| Concall | 2020-12-31 | TRANSCRIPT | — | Date_20210225_Aurobindo Pharma Ltd._Concal_Q3FY21.pdf |
| Concall | 2021-03-31 | TRANSCRIPT | — | Date_20210611_Aurobindo Pharma Ltd._Concal_Q4FY21.pdf |
| Concall | 2021-06-30 | TRANSCRIPT | — | Date_20210825_Aurobindo Pharma Ltd._Concal_Q1FY22.pdf |
| Concall | 2021-09-30 | TRANSCRIPT | — | Date_20211119_Aurobindo Pharma Ltd._Concal_Q2FY22.pdf |
| Concall | 2021-12-31 | TRANSCRIPT | — | Date_20220217_Aurobindo Pharma Ltd._Concal_Q3FY22.pdf |
| Concall | 2022-03-31 | TRANSCRIPT | — | Date_20220606_Aurobindo Pharma Ltd._Concal_Q4FY22.pdf |
| Concall | 2022-06-30 | TRANSCRIPT | — | Date_20220819_Aurobindo Pharma Ltd._Concal_Q1FY23.pdf |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221118_Aurobindo Pharma Ltd._Concal_Q2FY23.pdf |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230217_Aurobindo Pharma Ltd._Concal_Q3FY23.pdf |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20240216_Aurobindo Pharma Ltd._Concal_Q3FY23.pdf |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230601_Aurobindo Pharma Ltd._Concal_Q4FY23.pdf |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230818_Aurobindo Pharma Ltd._Concal_Q1FY24.pdf |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20240816_Aurobindo Pharma Ltd._Concal_Q1FY24.pdf |
| Concall | 2023-09-30 | TRANSCRIPT | — | Date_20231115_Aurobindo Pharma Ltd._Concal_Q2FY24.pdf |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20240531_Aurobindo Pharma Ltd._Concal_Q4FY24.pdf |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241118_Aurobindo Pharma Ltd._Concal_Q2FY25.pdf |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20260216_Aurobindo Pharma Ltd._Concal_Q3FY25.pdf |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250213_Aurobindo Pharma Ltd._Concal_FYFY25.pdf |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250602_Aurobindo Pharma Ltd._Concal_Q4FY25.pdf |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250808_Aurobindo Pharma Ltd._Concal_Q1FY26.pdf |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251111_Aurobindo Pharma Ltd._Concal_Q2FY26.pdf |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260527_Aurobindo Pharma Ltd._Concal_Q4FY26.pdf |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260813_Aurobindo Pharma Ltd._Concal_Q1FY27.pdf |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161518_529614_12102021031829_WEB.xml |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164755_589872_17012022031323_WEB.xml |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_167156_636995_16042022110032_WEB.xml |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169862_692995_18072022035024_WEB.xml |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_172080_735322_20102022100151_WEB.xml |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_174438_768811_17012023120310_WEB.xml |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176580_818733_14042023122410_WEB.xml |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179603_891661_19072023122205_WEB.xml |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_181652_953216_16102023024339_WEB.xml |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183359_1010330_08012024025912_WEB.xm |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_185835_1081377_05042024033430_WEB.xm |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_188803_1175631_09072024121105_WEB.xm |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191793_1267675_14102024125257_WEB.xm |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_194478_1343799_13012025043701_WEB.xm |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197288_1415039_15042025054751_WEB.xm |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1482952_15072025022756_WEB.xml |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1546245_13102025043353_WEB.xml |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1599979_13012026051655_WEB.xml |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1653158_17042026040030_WEB.xml |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1693124_15072026033059_WEB.xml |
| Related-party XBRL | 2022-03-31 | — | — | RPT_AUROPHARMA_10082022145605.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_AUROPHARMA_25112022230112.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_AUROPHARMA_29122022150426.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_855510_27052023082734_WEB.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_900486_26072023040458_WEB.xml |
| Related-party XBRL | 2023-09-30 | — | — | RPT_984062_09112023085100_WEB.xml |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1139371_25052024073133_WEB.xml |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1303297_09112024090949_WEB.xml |